Navigation Links
OmniComm Systems' Awarded 4 Clinical Trials from U.S. Biotechnology Company
Date:4/5/2011

FORT LAUDERDALE, Fla., April 5, 2011 /PRNewswire/ -- OmniComm Systems, Inc. (OTC: OMCM), one of the fastest growing companies in the EDC marketplace, today announced that its TrialMaster® suite of applications and IVRS technology has been chosen by a prominent biotechnology company to manage their clinical data management and randomization needs for 4 key clinical trials.  All 4 studies, leveraging OmniComm's Software-as-a-Service (SaaS) rapid-deployment model, will be put into production by the end of May.

"We are honored to be chosen by this biotech firm to manage so many key studies," said Stephen Johnson, President & COO of OmniComm.  "Our past experience with this company, and the trust that we've built with them to get these studies up and running under such tight timelines, were pivotal in their selection of OmniComm.  We look forward to the challenge."

OmniComm has also recently become a Society for Clinical Data Management CCDM® partner, an achievement that is only bestowed upon companies that are committed to quality clinical data management and Certified Clinical Data Manager (CCDM) credentialing.  Qualifying companies must have at least 10 certified CCDMs or 25% of CDMs must have achieved certification.

About OmniComm

OmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.

Safe Harbor Disclaimer

Statements made by OmniComm included in this release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise.

CONTACT:
Bev Hudson
OmniComm Systems, Inc.
954-473-1254
bhudson@omnicomm.com


'/>"/>
SOURCE OmniComm Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
2. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
3. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
4. OmniComm Systems, Inc. Announces 2010 First Half Results
5. OmniComm Systems Announces Auditor Change
6. OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting
7. Beardsworth® Selects OmniComm Systems® AE Reporting System
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
11. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... S.C. , July 10, 2017  BDI ... purchasing and patient support services organization serving specialty ... today the launch of four significant, value-added member ... market insights, better manage reimbursement and improve access ... and factor therapies. ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology:
(Date:7/24/2017)... SANTA CLARA, CA (PRWEB) , ... July 24, 2017 , ... ... government and financial organizations, today announced it has partnered with WALLIX to ... NIST Special Publication 800-171 . , There are a number of ways to address ...
(Date:7/24/2017)... ... July 24, 2017 , ... Anyone who uses scales know they ... would a pharmacist using that same scale to dispense medication. The first example is ... These illustrations show why it is important to have the right balance for the ...
(Date:7/24/2017)... ... 24, 2017 , ... A Southern California-based author has released a new book ... she has overcome them. “Forbidden Memories: A Memoir,” by author Michelle V. Madsen, highlights ... risen above. , In “Memories,” readers get a firsthand look at what Michelle has ...
(Date:7/24/2017)... (PRWEB) , ... July 24, 2017 , ... ... how to change manufacturers future. , The agency is hammering out a game ... one of the farthest-ranging laws ever to affect FDA-regulated firms. The new law:, ...
(Date:7/24/2017)... ... 24, 2017 , ... “A Short Walk to the Mailbox”: a remarkable memoir ... of published author, Ed Clark. Ed Clark is a church music director and ... a minister of music and worship leader for over fifty years. He has ...
Breaking Medicine News(10 mins):